Immuneering Corp — Director's Dealing 2023

Apr 24, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2023-04-20

Reporting Person: Cormorant Asset Management, LP (N/A)
Reporting Person: Cormorant Global Healthcare Master Fund, LP (N/A)
Reporting Person: Cormorant Private Healthcare Fund III LP (N/A)
Reporting Person: Chen Bihua (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	4204364	Indirect

Footnotes

F1: Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of Cormorant Global Healthcare Master Fund, LP (the "Master Fund") and Cormorant Private Healthcare Fund III, LP ("Fund III"). Cormorant Global Healthcare GP, LLC ("GP LLC") and Cormorant Private Healthcare GP III, LLC ("GP III") serve as General Partner of the Master Fund and Fund III, respectively. Bihua Chen serves as manager of Cormorant, GP LLC and GP III. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.

F2: Represents (i) 1,996,779 shares of Class A Common Stock beneficially owned by the Master Fund and (ii) 2,207,585 shares of Class A Common Stock beneficially owned by Fund III.